Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

NCT07581145 · Recruiting

Last updated 2026-05-28

This clinical trial tests whether the medication semaglutide helps heal foot ulcers in people with type 2 diabetes.

Status Recruiting Currently enrolling participants.

Phase Phase 3 Confirms effectiveness in a large group before approval.

Type Interventional (clinical trial)

Design Randomized, quadruple-blind treatment study

Participants 52 people Planned (estimated).

Who can join Ages 18–90 · all sexes

Timeline Started 2026-04 · est. completion 2029-12

Where 1 site · Denmark

What this study is testing ClinicalTrials.gov NCT07581145 ↗

Description as written by the study sponsor.

The aim of this exploratory pilot study is to investigate the effect of semaglutide compared to placebo on healing of foot ulcers in type 2 diabetes patients. It is a randomized double blind, placebo controlled, clinical intervention study of 20 weeks intervention.

Treatments tested

Semaglutide, 1.34 mg/mL also known as ozempic Drug

pen for subcutaneous injections
Placebo Drug

pen for subcutaneous injections

Main thing measured	Proportion of clinical healed index foot ulcer at week 20
Sponsor	Ole Lander Svendsen
Conditions studied	Foot Ulcer Due to Type 2 Diabetes Mellitus
GLP-1 drugs	semaglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07581145 ↗